Psychiatry
Cannabis Use Disorder
1
Pipeline Programs↗
9
Active Trials↗
0
Companies Involved↗
Cannabis Use Disorder is an early-stage landscape with 1 program across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
23
clinical trials
Completed12 · 52%
Recruiting6 · 26%
Not yet recruiting3 · 13%
Terminated2 · 9%
Clinical Trials
Trial Activity
23 trials
Tirzepatide for the Treatment of Cannabis Use Disorder
Not yet recruiting·—·Phase 2·NCT07265752·6 enrolled
Advancing Pregnenolone as a Novel Therapy for Co-Occurring Cannabis Use Disorder and Depression
Not yet recruiting·UUniversity of Texas Southwestern Medical Center·Preclinical·NCT07685964·20 enrolled
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
Completed·—·Phase 2·NCT05322941·333 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)